Company: RGNT
Filing Date: 2025-07-07
Form Type: F-1/A
Source: 0001213900-25-061821
Chunk: 187

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-07-07
Form: F-1/A
Chunk 187
---
 be entitled to 10% of our profits or to appoint a director to our board of directors)
and are Israeli residents, favorable tax treatment for compensation in the form of shares or options issued or granted, as applicable,
to a trustee under the “capital gains track” for the benefit of the applicable employee, director or officer and are (or
were) to be held by the trustee for at least two years after the date of grant or issuance. Options granted under Section 102 of the
Ordinance will be deposited with a trustee appointed by us in accordance with Section 102 of the Ordinance and the relevant income tax
regulations and guidelines, and will be granted in the employee income track or the capital gains track.

Options granted under the
2009 Plan are subject to applicable vesting schedules and generally expire 10 years from the grant date. In the event that options allocated
under the 2009 Plan expire or otherwise terminate in accordance with the provisions of the 2009 Plan, such expired or terminated options
will become available for future grant awards and allocations under the 2009 Plan.

2024 Option Plan

We adopted our 2024 Share
Option Plan, or the 2024 Plan, in July 2024, and it is scheduled to expire in July 2034. The 2024 Plan provides for the grant of options
to our employees, directors, officers, consultants, advisors, suppliers, and any other person or entity whose services are considered
valuable. As of July 7, 2025, 165,000 authorized but unissued Ordinary Shares were reserved for issuance under the 2024 Plan, subject
to certain adjustment as set forth therein, and no options were outstanding.

The 2024 Plan provides for
options to be granted at the determination of our board of directors (which is entitled to delegate its powers under the 2024 Plan to
our compensation committee) subject to applicable laws. Upon termination of employment for any reason, other than in the event of death
or disability or for cause, all unvested options will expire and all vested options at the time of termination will generally be exercisable
for 90 days following termination, subject to the terms of the 2024 Plan and the governing option agreement. If we terminate a grantee’s
employment or engagement for cause (as defined in the 2024 Plan) the grantee’s right to exercise all vested and unvested options
granted to him or her will expire immediately.